241 related articles for article (PubMed ID: 29048990)
1. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.
Cruz E; Cain J; Crossett B; Kayser V
Hum Vaccin Immunother; 2018 Mar; 14(3):508-517. PubMed ID: 29048990
[TBL] [Abstract][Full Text] [Related]
2. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
[TBL] [Abstract][Full Text] [Related]
3. Multi-task learning sparse group lasso: a method for quantifying antigenicity of influenza A(H1N1) virus using mutations and variations in glycosylation of Hemagglutinin.
Li L; Chang D; Han L; Zhang X; Zaia J; Wan XF
BMC Bioinformatics; 2020 May; 21(1):182. PubMed ID: 32393178
[TBL] [Abstract][Full Text] [Related]
4. Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses.
Saxena SK; Mishra N; Saxena R; Swamy ML; Sahgal P; Saxena S; Tiwari S; Mathur A; Nair MP
J Infect Dev Ctries; 2009 Nov; 4(1):1-6. PubMed ID: 20130371
[TBL] [Abstract][Full Text] [Related]
5. N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.
Sun X; Jayaraman A; Maniprasad P; Raman R; Houser KV; Pappas C; Zeng H; Sasisekharan R; Katz JM; Tumpey TM
J Virol; 2013 Aug; 87(15):8756-66. PubMed ID: 23740978
[TBL] [Abstract][Full Text] [Related]
6. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.
Job ER; Deng YM; Barfod KK; Tate MD; Caldwell N; Reddiex S; Maurer-Stroh S; Brooks AG; Reading PC
J Immunol; 2013 Mar; 190(5):2169-77. PubMed ID: 23365085
[TBL] [Abstract][Full Text] [Related]
7. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
[TBL] [Abstract][Full Text] [Related]
8. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses.
Sun S; Wang Q; Zhao F; Chen W; Li Z
PLoS One; 2012; 7(2):e32119. PubMed ID: 22355413
[TBL] [Abstract][Full Text] [Related]
9.
An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
[TBL] [Abstract][Full Text] [Related]
10. Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.
Ushirogawa H; Naito T; Tokunaga H; Tanaka T; Nakano T; Terada K; Ohuchi M; Saito M
BMC Infect Dis; 2016 Aug; 16():380. PubMed ID: 27503338
[TBL] [Abstract][Full Text] [Related]
11. Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines.
She YM; Farnsworth A; Li X; Cyr TD
Sci Rep; 2017 Aug; 7(1):10232. PubMed ID: 28860626
[TBL] [Abstract][Full Text] [Related]
12. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.
Medina RA; Stertz S; Manicassamy B; Zimmermann P; Sun X; Albrecht RA; Uusi-Kerttula H; Zagordi O; Belshe RB; Frey SE; Tumpey TM; García-Sastre A
Sci Transl Med; 2013 May; 5(187):187ra70. PubMed ID: 23720581
[TBL] [Abstract][Full Text] [Related]
13. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
[TBL] [Abstract][Full Text] [Related]
14. Analysis of antigen epitopes and molecular pathogenic characteristics of the 2009 H1N1 pandemic influenza A virus in China.
Zhou JJ; Tian J; Fang DY; Liang Y; Yan HJ; Zhou JM; Gao HL; Fu CY; Liu Y; Ni HZ; Ke CW; Jiang LF
Acta Virol; 2011; 55(3):195-202. PubMed ID: 21978153
[TBL] [Abstract][Full Text] [Related]
15. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.
Igarashi M; Ito K; Yoshida R; Tomabechi D; Kida H; Takada A
PLoS One; 2010 Jan; 5(1):e8553. PubMed ID: 20049332
[TBL] [Abstract][Full Text] [Related]
16. Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry.
Blake TA; Williams TL; Pirkle JL; Barr JR
Anal Chem; 2009 Apr; 81(8):3109-18. PubMed ID: 19290601
[TBL] [Abstract][Full Text] [Related]
17. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in mice.
Zhang Y; Zhu J; Li Y; Bradley KC; Cao J; Chen H; Jin M; Zhou H
PLoS One; 2013; 8(4):e61397. PubMed ID: 23637827
[TBL] [Abstract][Full Text] [Related]
19. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.
Sautto GA; Kirchenbaum GA; Ecker JW; Bebin-Blackwell AG; Pierce SR; Ross TM
Immunohorizons; 2018 Aug; 2(7):226-237. PubMed ID: 31022693
[TBL] [Abstract][Full Text] [Related]
20. Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.
Al Khatib HA; Al Thani AA; Yassine HM
Arch Virol; 2018 Nov; 163(11):3035-3049. PubMed ID: 30066273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
